Ethics of outsourcing drug trials

Research output: Chapter in Book/Report/Conference proceedingChapter


With rising costs of drug testing and more stringent requirements, Western countries have been increasingly outsourcing their drug trials. While such actions make sense from a cost-benefit point of view, can we conclude the same from a marketing-ethics perspective? Are these lesser-developed countries being held to the same ethical standards and practices as expected in the Western countries? Are the drug companies' actions somehow influencing the research participants' decision to partake in such trials? The author applies the theory of reasoned action and ethical marketing underpinnings to develop relevant propositions. Consequently, drug testing companies, research participants, and marketing agencies can utilize these propositions to investigate whether more rigorous oversight is required to protect research participants.

Original languageEnglish (US)
Title of host publicationResearch Anthology on Business Law, Policy, and Social Responsibility
PublisherIGI Global
Number of pages19
ISBN (Electronic)9798369320464
ISBN (Print)9798369320457
StatePublished - Dec 21 2023

All Science Journal Classification (ASJC) codes

  • General Social Sciences
  • General Economics, Econometrics and Finance
  • General Business, Management and Accounting

Cite this